drugset / Trial / NCT01377974
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether miltefosine is effective in the treatment of mucosal leishmaniasis compared to meglumine antimoniate, the standard treatment.
Timeline
- Start
- 2009-07
- Primary completion
- 2013-06
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Meglumine antimonate | Other / unclassified | 20 mg/kg | Intravenous |
| Subject | Miltefosine | Small molecule | 50 mg | Oral |